Apollo Medical Hlgs Q4 2023 GAAP EPS $0.26 Beats $0.15 Estimate, Sales $353.04M Beat $340.61M Estimate
Portfolio Pulse from Benzinga Newsdesk
Apollo Medical Holdings (AMEH) reported Q4 2023 earnings of $0.26 per share, surpassing the $0.15 estimate, with sales of $353.04M also beating the $340.61M estimate, marking a 20% increase from the previous year.

February 27, 2024 | 9:55 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Apollo Medical Holdings (AMEH) exceeded Q4 2023 earnings and sales estimates, with a significant year-over-year sales increase.
AMEH's reported earnings and sales not only surpassed analyst expectations but also showed a substantial year-over-year growth. This performance is likely to instill confidence among investors, potentially leading to a positive short-term impact on the stock price. The significant beat on both earnings per share (EPS) and sales, coupled with a 20% increase in sales compared to the same period last year, highlights the company's strong financial health and operational efficiency.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100